Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (2): 111-114.doi: 10.3736/jcim20080201

• Editorial •     Next Articles

Cancerous toxin is the key pathogenic factor of malignant tumor

Chang-quan Ling()   

  1. School of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China
  • Received:2007-10-24 Online:2008-02-20 Published:2008-02-15
  • Contact: LING Chang-quan

The definition of cancerous toxin and the relationships between cancerous toxin and other factors including the etiopathogenesis, pathogenesis and treatment of malignant tumor were discussed in this paper. The author suggests that the cancerous toxin is engendered by the disequilibrium of human body, which is the foundation of tumorigenesis. Cancerous toxin is the main pathogenic factor or one of the main pathogenic factors during the development of malignant tumor, hence it is also the key point for understanding and treating malignant tumor.

Key words: carcinoma, neoplasms, medicine, Chinese traditional, etiological factors and pathogenesis (traditional Chinese medicine), toxin

CLC Number: 

  • R730.231
[1] Wang JH. The status and effect of traditional Chinese medicine in treatment of malignant tumor. Jiangsu Zhong Yi. 2001; 22(11):1-3. Chinese.
王锦鸿 . 中医在治疗恶性肿瘤中的作用与地位.江苏中医. 2001; 22(11):1-3.
[2] Ling CQ . Problems in cancer treatment and major research of integrative medicine. Zhong Xi Yi Jie He Xue Bao. 2003; 1(3):168-170. Chinese with abstract in English.
凌昌全 . 肿瘤治疗存在的问题及中西医结合的研究重点.中西医结合学报. 2003; 1(3):168-170.
[3] Yu RC. Oncology of traditional Chinese medicine. Beijing: Science Press. 1983: 12-25. Chinese.
郁仁存 . 中医肿瘤学.北京: 科学出版社. 1983: 12-25.
[4] Xia X, Wang QQ. Collection of academic experience of Shanghai famous traditional Chinese medicine doctors. Beijing: Peoples Medical Publishing House. 2006: 896- 909. Chinese.
夏翔, 王庆其 . 上海市名中医学术经验集.北京: 人民卫生出版社. 2006: 896-909.
[5] Yu LF. Collected works of Shanghai famous and senior traditional Chinese medicine doctors" experience in treating digestive system diseases. Beijing: China Press of Traditional Chinese Medicine. 2007: 51-72. Chinese.
余莉芳 . 上海名老中医治疗消化病经验精粹.北京: 中国中医药出版社. 2007: 51-72.
[6] Huang YS. Tentative analysis of treatment of lung cancer with the theory of cancerous toxin Shannxi Zhong Yi. 2005; 26(10):1077-1078. Chinese.
doi: 10.3969/j.issn.1000-7369.2005.10.069
黄云胜 . 从癌毒论治肺癌浅析.陕西中医. 2005; 26(10):1077-1078.
doi: 10.3969/j.issn.1000-7369.2005.10.069
[7] Shu P , Liu SL. Tentative analysis of differentiation and treatment structure of traditional Chinese medicine oncology. Jilin Zhong Yi Yao. 2005; 25(7):4-7. Chinese.
doi: 10.3969/j.issn.1003-5699.2005.07.002
舒鹏, 刘沈林 . 中医肿瘤学证治体系浅析.吉林中医药. 2005; 25(7):4-7.
doi: 10.3969/j.issn.1003-5699.2005.07.002
[8] Li JY. Exploration of concept of pathology and clinical treatment of cancerous toxin. Jiangxi Zhong Yi Yao. 2005; 36(8):14-15. Chinese.
doi: 10.3969/j.issn.0411-9584.2005.08.008
李俊玉 . 癌毒的病因病机及临证治法的概念探析.江西中医药. 2005; 36(8):14-15.
doi: 10.3969/j.issn.0411-9584.2005.08.008
[9] Chen SQ. Professor Zhou Zhong-ying’s experience on the treatment of tumor by differentiation of cancerous toxin. Xin Zhong Yi. 2004; 36(2):7-9. Chinese.
doi: 10.3969/j.issn.0256-7415.2004.02.002
陈四清 . 周仲瑛教授从癌毒辨治肿瘤经验.新中医. 2004; 36(2):7-9.
doi: 10.3969/j.issn.0256-7415.2004.02.002
[10] Dai XJ , Zhu YM. Tentative analysis of tumour pathology and pharmacology of "treatment on the basis of toxin" in treating tumour and clinical practice on indication. Zhong Yi Yao Xue Kan. 2002; 20(1):67. Chinese.
doi: 10.3969/j.issn.1673-7717.2002.01.035
戴小军 , 朱娅敏从毒论治肿瘤病理药理基础与临证应用浅释. 中医药学刊. 2002; 20(1):67.
doi: 10.3969/j.issn.1673-7717.2002.01.035
[11] Jia LQ , Huang JC. Treating the malignant tumor by "combatting toxin with toxin" prescription. Zhong Ri You Hao Yi Yuan Xue Bao. 2000; 14(2):117-120. Chinese.
贾立群 , 黄金昶以毒攻毒方药治疗恶性肿瘤.中日友好医院学报. 2000; 14(2):117-120.
[12] Lu Y . Discussion and study of cancer treatment. Hubei Zhong Yi Za Zhi. 1992; 14(4):42. Chinese.
卢疑 .谈癌论治. 湖北中医杂志. 1992; 14(4):42.
[13] Chang FY , Wang YY. Toxic pathogen theory of apoplexy. Beijing Zhong Yi Yao Da Xue Xue Bao. 2004; 27(1):3-6. Chinese.
常富业, 王永炎 . 中风病毒邪论.北京中医药大学学报. 2004; 27(1):3-6.
[14] Liu GS . Study of toxin and pathology. Shandong Zhong Yi Xue Yuan Xue Bao. 1989; 13(1) : 3-5. Chinese.
刘更生 .论毒邪. 山东中医学院学报. 1989; 13(1):3-5.
[15] Liu BS. Oncology in human digestive system. Beijing: Peoples Medical Publishing House. 2004: 4. Chinese.
刘宝善 . 消化器官肿瘤学.北京: 人民卫生出版社. 2004: 4.
[16] Cai SR, Zheng S , Zhang SZ. Multivariate analysis of prognostic factors in colorectal cancer patients with different age. Zhonghua Zhong Liu Za Zhi. 2005; 27(8):483-485. Chinese with abstract in English.
蔡善荣, 郑树, 张苏展 . 不同年龄组大肠癌预后多因素分析的比较. 中华肿瘤杂志. 2005; 27(8):483-485.
[17] Wang ZY, Tang XH, Liu SX , et al. Contrast treatment of clinical and endoscopy to patients with colorectal cancer at different age group. Zhongguo Ji Ceng Yi Yao. 2006; 13(7):1173-1174. Chinese with abstract in English.
王振元, 唐小华, 刘胜雄 , 等. 不同年龄结直肠癌患者临床及内镜特点分析.中国基层医药. 2006; 13(7):1173-1174.
[18] Chen J, Xu DS, Zhang Y , et al. The relationship between age and the clinical characteristics of malignant kidney neoplasms in adult patients. Zhonghua Mi Niao Wai Ke Za Zhi. 2006; 27:93-96. Chinese with abstract in English.
doi: 10.3760/j:issn:1000-6702.2006.02.006
陈军, 徐柢顺, 张怡 , 等. 年龄因素与成人肾恶性肿瘤临床发病特点的关系.中华泌尿外科杂志. 2006; 27:93-96.
doi: 10.3760/j:issn:1000-6702.2006.02.006
[19] Cho SJ, Yoon JH, Hwang SS , et al. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol. 2007; 22(8):1226-1231.
doi: 10.1111/jgh.2007.22.issue-8
[20] Tang ZY. Clinical hepatocellular carcinoma. Shanghai : Shanghai Scientific and Technical Education Publishing House. 2001: 16. Chinese.
汤钊猷 . 临床肝癌学.上海: 上海科技教育出版社. 2001: 16.
[21] Gary Stix . A malignant flame. Understanding chronic inflammation, which contributes to heart disease, Alzheimer's and a variety of other ailments, may be a key to unlocking the mysteries of cancer. Sci Am. 2007; 297(1):60-67.
[1] Tara Rajendran. Addressing the need for personalizing music therapy in integrative oncology. Journal of Integrative Medicine, 2022, 20(4): 281-283.
[2] Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[3] Cai-lian Fana, Wan-jun Caib, Meng-nan Ye, Miao Chen, Yi Dai. Qili Qiangxin, a compound herbal medicine formula, alleviates hypoxia-reoxygenation-induced apoptotic and autophagic cell death via suppression of ROS/AMPK/mTOR pathway in vitro. Journal of Integrative Medicine, 2022, 20(4): 365-375.
[4] Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.
[5] Vibha Malhotra, Joanna Harnett, Erica McIntyre, Amie Steel, Keith Wong, Bandana Saini. To “tell or not to tell”—Exploring disclosure about medicine use by people living with sleep disorders. Journal of Integrative Medicine, 2022, 20(4): 338-347.
[6] Maryam Azimi, Hanieh Niayesh, Mahboobeh Raeiszadeh, Sedigheh Khodabandeh-shahraki. Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation: A double-blind randomized controlled tria. Journal of Integrative Medicine, 2022, 20(3): 230-236.
[7] Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[8] Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[9] Tareq A. Wani, Zahoor A. Kaloo, Nisar A. Dangroo. Aconitum heterophyllum Wall. ex Royle: A critically endangered medicinal herb with rich potential for use in medicine. Journal of Integrative Medicine, 2022, 20(2): 104-113.
[10] Mohammad Fazil, Sadia Nikhat. Why the “sugars” in traditional Unani formulations are a pivotal component: A viewpoint perspective. Journal of Integrative Medicine, 2022, 20(2): 91-95.
[11] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[12] Deng-chao Wang, Miao Yu, Wen-xian Xie, Li-yan Huang, Jian Wei, Yue-hua Lei. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019. Journal of Integrative Medicine, 2022, 20(1): 26-33.
[13] Mahlagha Dehghan, Alireza Ghanbari, Fatemeh Ghaedi Heidari, Parvin Mangalian, Mohammad Ali Zakerid. Use of complementary and alternative medicine in general population during COVID-19 outbreak: A survey in Iran. Journal of Integrative Medicine, 2022, 20(1): 45-51.
[14] Jose Antonio Castilla-Jimena, Isabel Ruiz-Pérez, Jesús Henares-Montiel. Impact of socioeconomic and health-related factors on consumption of homeopathic and natural remedies in Spain in 2006, 2011 and 2017. Journal of Integrative Medicine, 2022, 20(1): 52-56.
[15] Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228